PRECIGEN, INC.
PGENdata completeness 100%15 fiscal years on filePRECIGEN, INC. earns about -270% on invested capital, but has diluted owners by 58% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $14.3M1 | $26.9M1 | $6.23M2 | $3.93M2 | $9.68M2 |
| Net income | −$92.2M3 | $28.3M4 | −$95.9M5 | −$126.2M5 | −$250.6M5 |
| Operating cash flow | −$55.8M6 | −$65M7 | −$66.9M8 | −$68.2M8 | −$87.8M8 |
| Capital expenditure | $7.25M9 | $4.92M10 | $1.54M11 | $8.58M11 | $2M11 |
| Free cash flow (derived) | −$63M6 | −$70M7 | −$68.5M8 | −$76.8M8 | −$89.8M8 |
| Total debt | $359.9M12 | $129.7M12 | $013 | $014 | $186.3M14 |
| Cash & equivalents | $36.4M15 | $4.86M16 | $7.58M17 | $29.5M18 | $30.2M18 |
| Diluted shares | 197.8M | 200.4M | 244.5M | 267.7M | 313.0M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $0.67 of net worth that earned you −$8.01 and generated −$2.87 of cash last year, against $5.95 of debt.
It earned an average -270% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 58% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has fallen 48% — deleveraging.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001356090-23-000004 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001356090-26-000009 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0001356090-24-000007 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001356090-25-000007 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001356090-26-000009 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001356090-24-000007 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001356090-25-000007 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001356090-26-000009 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001356090-24-000007 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001356090-25-000007 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001356090-26-000009 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-12-31 · accession 0001356090-23-000004 (LongTermDebtNoncurrent)
- 10-K · period ending 2023-12-31 · accession 0001356090-24-000007 (ShortTermBorrowings)
- 10-K · period ending 2024-12-31 · accession 0001356090-26-000009 (LongTermDebtNoncurrent)
- 10-K · period ending 2021-12-31 · accession 0001356090-23-000004 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001356090-24-000007 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001356090-25-000007 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001356090-26-000009 (CashAndCashEquivalentsAtCarryingValue)